Glycogen Synthase Kinase 3α-Specific Regulation of Murine Hepatic Glycogen Metabolism

Cell Metabolism

Volumn 6, Issue 4, 2007, Pages 329-337

  MacAulay, Katrina ^a   Doble, Bradley W ^a   Patel, Satish ^a   Hansotia, Tanya ^a   Sinclair, Elaine M ^a   Drucker, Daniel J ^a   Nagy, Andras ^a   Woodgett, James R ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

Author keywords

HUMDISEASE

Indexed keywords

GLUCOSE; GLYCOGEN SYNTHASE KINASE 3ALPHA; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; PROTEIN KINASE B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG TARGETING; GLUCOSE TOLERANCE; GLUCOSE TOLERANCE TEST; GLYCOGEN ANALYSIS; GLYCOGEN METABOLISM; INSULIN SENSITIVITY; KNOCKOUT MOUSE; LIVER; MALE; MOUSE; MUSCLE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; WILD TYPE;

ANIMALS; GLUCOSE; GLYCOGEN SYNTHASE KINASE 3; INSULIN; ISOENZYMES; LIVER; LIVER GLYCOGEN; MICE; MICE, KNOCKOUT; PROTO-ONCOGENE PROTEINS C-AKT;

ANIMALIA; MURINAE; MUS; RODENTIA;

EID: 34548841091     PISSN: 15504131     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cmet.2007.08.013     Document Type: Article

References (38)

1. Amalfitano A., McVie-Wylie A.J., Hu H., Dawson T.L., Raben N., Plotz P., and Chen Y.T. Systemic correction of the muscle disorder glycogen storage disease type II after hepatic targeting of a modified adenovirus vector encoding human acid-alpha-glucosidase. Proc. Natl. Acad. Sci. USA 96 (1999) 8861-8866
2. Bondar R.J., and Mead D.C. Evaluation of glucose-6-phosphate dehydrogenase from Leuconostoc mesenteroides in the hexokinase method for determining glucose in serum. Clin. Chem. 20 (1974) 586-590
3. Carey P.E., Halliday J., Snaar J.E., Morris P.G., and Taylor R. Direct assessment of muscle glycogen storage after mixed meals in normal and type 2 diabetic subjects. Am. J. Physiol. Endocrinol. Metab. 284 (2003) E688-E694
4. Ciaraldi T.P., Nikoulina S.E., Bandukwala R.A., Carter L., and Henry R.R. Role of glycogen synthase kinase-3{alpha} in insulin action in cultured human skeletal muscle cells. Endocrinology 148 (2007) 4393-4399
5. Cline G.W., Rothman D.L., Magnusson I., Katz L.D., and Shulman G.I. 13C-nuclear magnetic resonance spectroscopy studies of hepatic glucose metabolism in normal subjects and subjects with insulin-dependent diabetes mellitus. J. Clin. Invest. 94 (1994) 2369-2376
6. Cline G.W., Johnson K., Regittnig W., Perret P., Tozzo E., Xiao L., Damico C., and Shulman G.I. Effects of a novel glycogen synthase kinase-3 inhibitor on insulin-stimulated glucose metabolism in Zucker diabetic fatty (fa/fa) rats. Diabetes 51 (2002) 2903-2910
7. Coghlan M.P., Culbert A.A., Cross D.A., Corcoran S.L., Yates J.W., Pearce N.J., Rausch O.L., Murphy G.J., Carter P.S., Roxbee Cox L., et al. Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription. Chem. Biol. 7 (2000) 793-803
8. Damsbo P., Vaag A., Hother-Nielsen O., and Beck-Nielsen H. Reduced glycogen synthase activity in skeletal muscle from obese patients with and without type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 34 (1991) 239-245
9. Doble B.W., Patel S., Wood G.A., Kockeritz L.K., and Woodgett J.R. Functional redundancy of GSK-3alpha and GSK-3beta in Wnt/beta-catenin signaling shown by using an allelic series of embryonic stem cell lines. Dev. Cell 12 (2007) 957-971
10. Dokken B.B., Sloniger J.A., and Henriksen E.J. Acute selective glycogen synthase kinase-3 inhibition enhances insulin signaling in prediabetic insulin-resistant rat skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 288 (2005) E1188-E1194
11. Eldar-Finkelman H., Argast G.M., Foord O., Fischer E.H., and Krebs E.G. Expression and characterization of glycogen synthase kinase-3 mutants and their effect on glycogen synthase activity in intact cells. Proc. Natl. Acad. Sci. USA 93 (1996) 10228-10233
12. Eldar-Finkelman H., Schreyer S.A., Shinohara M.M., LeBoeuf R.C., and Krebs E.G. Increased glycogen synthase kinase-3 activity in diabetes- and obesity-prone C57BL/6J mice. Diabetes 48 (1999) 1662-1666
13. Embi N., Rylatt D.B., and Cohen P. Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase. Eur. J. Biochem. 107 (1980) 519-527
14. Frame S., Cohen P., and Biondi R.M. A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation. Mol. Cell 7 (2001) 1321-1327
15. Friedman J.M., and Halaas J.L. Leptin and the regulation of body weight in mammals. Nature 395 (1998) 763-770
16. George S.H., Gertsenstein M., Vintersten K., Korets-Smith E., Murphy J., Stevens M.E., Haigh J.J., and Nagy A. Developmental and adult phenotyping directly from mutant embryonic stem cells. Proc. Natl. Acad. Sci. USA 104 (2007) 4455-4460
17. Henriksen E.J., Kinnick T.R., Teachey M.K., O'Keefe M.P., Ring D., Johnson K.W., and Harrison S.D. Modulation of muscle insulin resistance by selective inhibition of GSK-3 in Zucker diabetic fatty rats. Am. J. Physiol. Endocrinol. Metab. 284 (2003) E892-E900
18. Henry R.R., Ciaraldi T.P., Abrams-Carter L., Mudaliar S., Park K.S., and Nikoulina S.E. Glycogen synthase activity is reduced in cultured skeletal muscle cells of non-insulin-dependent diabetes mellitus subjects. Biochemical and molecular mechanisms. J. Clin. Invest. 98 (1996) 1231-1236
19. Hoeflich K.P., Luo J., Rubie E.A., Tsao M.S., Jin O., and Woodgett J.R. Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation. Nature 406 (2000) 86-90
20. Kaidanovich O., and Eldar-Finkelman H. The role of glycogen synthase kinase-3 in insulin resistance and Type 2 diabetes. Expert Opin. Ther. Targets 6 (2002) 555-561
21. Kaidanovich-Beilin O., and Eldar-Finkelman H. Long-term treatment with novel glycogen synthase kinase-3 inhibitor improves glucose homeostasis in ob/ob mice: molecular characterization in liver and muscle. J. Pharmacol. Exp. Ther. 316 (2006) 17-24
22. Kerouz N.J., Horsch D., Pons S., and Kahn C.R. Differential regulation of insulin receptor substrates-1 and -2 (IRS-1 and IRS-2) and phosphatidylinositol 3-kinase isoforms in liver and muscle of the obese diabetic (ob/ob) mouse. J. Clin. Invest. 100 (1997) 3164-3172
23. Li X., Yu Y., Wei W., Yong J., Yang J., You J., Xiong X., Qing T., and Deng H. Simple and efficient production of mice derived from embryonic stem cells aggregated with tetraploid embryos. Mol. Reprod. Dev. 71 (2005) 154-158
24. Liberman Z., and Eldar-Finkelman H. Serine 332 phosphorylation of insulin receptor substrate-1 by glycogen synthase kinase-3 attenuates insulin signaling. J. Biol. Chem. 280 (2005) 4422-4428
25. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
26. MacAulay K., Hajduch E., Blair A.S., Coghlan M.P., Smith S.A., and Hundal H.S. Use of lithium and SB-415286 to explore the role of glycogen synthase kinase-3 in the regulation of glucose transport and glycogen synthase. Eur. J. Biochem. 270 (2003) 3829-3838
27. MacAulay K., Blair A.S., Hajduch E., Terashima T., Baba O., Sutherland C., and Hundal H.S. Constitutive activation of GSK3 down-regulates glycogen synthase abundance and glycogen deposition in rat skeletal muscle cells. J. Biol. Chem. 280 (2005) 9509-9518
28. McManus E.J., Sakamoto K., Armit L.J., Ronaldson L., Shpiro N., Marquez R., and Alessi D.R. Role that phosphorylation of GSK3 plays in insulin and Wnt signalling defined by knockin analysis. EMBO J. 24 (2005) 1571-1583
29. Nikoulina S.E., Ciaraldi T.P., Mudaliar S., Mohideen P., Carter L., and Henry R.R. Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes. Diabetes 49 (2000) 263-271
30. Orena S.J., Torchia A.J., and Garofalo R.S. Inhibition of glycogen-synthase kinase 3 stimulates glycogen synthase and glucose transport by distinct mechanisms in 3T3-L1 adipocytes. J. Biol. Chem. 275 (2000) 15765-15772
31. Pearce N.J., Arch J.R., Clapham J.C., Coghlan M.P., Corcoran S.L., Lister C.A., Llano A., Moore G.B., Murphy G.J., Smith S.A., et al. Development of glucose intolerance in male transgenic mice overexpressing human glycogen synthase kinase-3beta on a muscle-specific promoter. Metabolism 53 (2004) 1322-1330
32. Pederson B.A., Schroeder J.M., Parker G.E., Smith M.W., DePaoli-Roach A.A., and Roach P.J. Glucose metabolism in mice lacking muscle glycogen synthase. Diabetes 54 (2005) 3466-3473
33. Roach P.J. Glycogen and its metabolism. Curr. Mol. Med. 2 (2002) 101-120
34. Ruiz-Alcaraz A.J., Liu H.K., Cuthbertson D.J., McManus E.J., Akhtar S., Lipina C., Morris A.D., Petrie J.R., Hundal H.S., and Sutherland C. A novel regulation of IRS1 (insulin receptor substrate-1) expression following short term insulin administration. Biochem. J. 392 (2005) 345-352
35. Shulman G.I., Cline G., Schumann W.C., Chandramouli V., Kumaran K., and Landau B.R. Quantitative comparison of pathways of hepatic glycogen repletion in fed and fasted humans. Am. J. Physiol. 259 (1990) E335-E341
36. Shulman G.I., Rothman D.L., Jue T., Stein P., DeFronzo R.A., and Shulman R.G. Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. N. Engl. J. Med. 322 (1990) 223-228
37. White M.F. IRS proteins and the common path to diabetes. Am. J. Physiol. Endocrinol. Metab. 283 (2002) E413-E422
38. Woodgett J.R. Molecular cloning and expression of glycogen synthase kinase-3/factor A. EMBO J. 9 (1990) 2431-2438